Alibaba Health Information Technology : CHANGE OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

阿 里 健 康 信 息 技 術 有 限 公 司

(Incorporated in Bermuda with limited liability)

(Stock code: 00241)

CHANGE OF COMPANY SECRETARY,

AUTHORIZED REPRESENTATIVE AND PROCESS AGENT

The Board announces that Ms. Lew Aishan Nicole has resigned as the Company Secretary, the Authorized Representative and the Process Agent of the Company with effect from August 24, 2020.

The Board also announces that Ms. Lee Wai Yan Vivian has been appointed as the Company Secretary, the Authorized Representative and the Process Agent of the Company with effect from August 24, 2020.

RESIGNATION OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT

The board of directors (the ''Board'') of Alibaba Health Information Technology Limited (the ''Company'', together with its subsidiaries, the ''Group'') announces that Ms. Lew Aishan Nicole (''Ms. Lew'') has tendered her resignation as the company secretary (the ''Company Secretary'') of the Company, and will cease to act as an authorized representative of the Company pursuant to Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ''Stock Exchange'') (the ''Authorized Representative'') and an authorized representative of the Company to accept service of process and notices in Hong Kong under the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) (the ''Process Agent'') with effect from August 24, 2020.

Ms. Lew has confirmed that she does not have any disagreement with the Board and there are no other matters in relation to her resignation that need to be brought to the attention of the shareholders of the Company and the Stock Exchange.

- 1 -

The Company would like to thank Ms. Lew for all her past contributions to the Group.

APPOINTMENT OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT

Following the resignation of Ms. Lew, the Board is pleased to announce that Ms. Lee Wai Yan Vivian (''Ms. Lee'') has been appointed as the Company Secretary, the Authorized Representative and the Process Agent with effect from August 24, 2020.

Ms. Lee has more than 10 years of working experience in the legal field. She was a senior legal director at Fosun International Limited (Stock Code: 0656) from December 2015 to December 2018. She also worked at the Hong Kong office of various international law firms from 2008 to 2015. Ms. Lee obtained a Bachelor of Arts degree from the University of British Columbia (Canada) and a Graduate Diploma in Law (Common Professional Examination) and qualified to practice law in England and Wales. She was admitted as a solicitor of the High Court of Hong Kong in 2007 and is currently a member of the Law Society of Hong Kong.

The Board would like to congratulate Ms. Lee on her new appointment.

By Order of the Board

Alibaba Health Information Technology Limited

ZHU Shunyan

Chairman and Chief Executive Officer

Hong Kong, August 24, 2020

As at the date of this announcement, the Board comprises eight directors, of which (i) two are executive Directors, namely Mr. ZHU Shunyan and Mr. WANG Qiang; (ii) three are non-executive Directors, namely Mr. WU Yongming, Mr. WANG Lei and Mr. XU Hong; and (iii) three are independent non-executive Directors, namely Mr. LUO Tong, Mr. WONG King On, Samuel and Ms. HUANG Yi Fei (Vanessa).

- 2 -